Browse > Article
http://dx.doi.org/10.1055/s-0042-1744422

Comprehensive Evaluation of the Current Knowledge on Breast Implant Associated-Anaplastic Large Cell Lymphoma  

Yoo, Hyokyung (Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Park, Ji-Ung (Department of Plastic and Reconstructive Surgery, Seoul National University Boramae Hospital, Seoul National University College of Medicine)
Chang, Hak (Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Publication Information
Archives of Plastic Surgery / v.49, no.2, 2022 , pp. 141-149 More about this Journal
Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently spotlighted T-cell origin non-Hodgkin's lymphoma with an increasing incidence of over 800 cases and 33 deaths reported worldwide. Development of BIA-ALCL is likely a complex process involving many factors, such as the textured implant surface, bacterial biofilm growth, immune response, and patient genetics. As the incidence of BIA-ALCL is expected to increase, it is important for all surgeons and physicians to be aware of this disease entity and acquire thorough knowledge of current evidence-based guidelines and recommendations. Early detection, accurate diagnosis, and appropriate treatment are the foundations of current care.
Keywords
BIA-ALCL; breast implants; biofilm; immunity; genetics;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Eaves F III, Nahai F. Anaplastic large cell lymphoma and breast implants: FDA report. Aesthet Surg J 2011;31(04):467-468   DOI
2 DeCoster RC, Lynch EB, Bonaroti AR, et al. Breast implant-associated anaplastic large cell lymphoma: an evidence-based systematic review. Ann Surg 2021;273(03):449-458   DOI
3 McCarthy CM, Loyo-Berrios N, Qureshi AA, et al. Patient registry and outcomes for breast implants and anaplastic large cell lymphoma etiology and epidemiology (PROFILE): initial report of findings, 2012-2018. Plast Reconstr Surg 2019;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):65S-73S   DOI
4 Clemens MW. BIA-ALCL Resources: by the numbers, and what they mean. c2021. Available at: https://www.plasticsurgery.-org/for-medical-professionals/health-policy/bia-alcl-physician--resources/by-the-numbers
5 Calobrace MB, Schwartz MR, Zeidler KR, Pittman TA, Cohen R, Stevens WG. Long-term safety of textured and smooth breast implants. Aesthet Surg J 2017;38(01):38-48   DOI
6 Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg 2015;135(02):319-329   DOI
7 Mempin M, Hu H, Chowdhury D, Deva A, Vickery K. The A, B and C's of silicone breast implants: anaplastic large cell lymphoma, biofilm and capsular contracture. Materials (Basel) 2018;11(12):2393   DOI
8 Deva AK, Turner SD, Kadin ME, et al. Etiology of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): current directions in research. Cancers (Basel) 2020;12(12):3861   DOI
9 Hu H, Johani K, Almatroudi A, et al. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg 2016;137(06):1659-1669   DOI
10 Statement from FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., and Jeff Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health on FDA's new efforts to protect women's health and help to ensure the safety of breast implants. C2021. Available at: https://www.fda.gov/news-events/pressannouncements/statement-fda-principal-deputy-commissioner-amyabernethy-md-phd-and-jeff-shuren-md-jd-director-fdas
11 Ashley FL. Further studies on the natural-Y breast prosthesis. Plast Reconstr Surg 1972;49(04):414-419   DOI
12 Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett 2014;345(02):196-202   DOI
13 TGA update on rare cancer associated with breast implants. Therapeutic Goods Administration. 2016; c2021. Available at: https://www.tga.gov.au/node/733726
14 Lee JH. Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). Yeungnam Univ J Med 2021;38(03):175-182   DOI
15 Henderson PW, Nash D, Laskowski M, Grant RT. Objective comparison of commercially available breast implant devices. Aesthetic Plast Surg 2015;39(05):724-732   DOI
16 Brody GS, Deapen D, Taylor CR, et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg 2015;135(03):695-705   DOI
17 de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300(17):2030-2035   DOI
18 McGuire P, Reisman NR, Murphy DK. Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg 2017;139(01):1-9   DOI
19 Laurent C, Delas A, Gaulard P, et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol 2016;27(02):306-314   DOI
20 Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure. C2021. Available at: https://healthycanadians.gc.ca/recall-alertrappel-avis/hc-sc/2019/69520a-eng.php
21 Ramos-Gallardo G, Cuenca-Pardo J, Rodriguez-Olivares E, et al. Breast implant and anaplastic large cell lymphoma meta-analysis. J Invest Surg 2017;30(01):56-65   DOI
22 George EV, Pharm J, Houston C, et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol 2013;6(08):1631-1642
23 Montes-Mojarro IA, Steinhilber J, Bonzheim I, Quintanilla-Martinez L, Fend F. The pathological spectrum of systemic anaplastic large cell lymphoma (ALCL). Cancers (Basel) 2018;10(04):107   DOI
24 Thienpaitoon P, Disphanurat W, Warnnissorn N. Breast implant-associated anaplastic large cell lymphoma in an Asian patient: the firstcase report from Thailand. Arch Plast Surg 2020;47(05):478-482   DOI
25 Cordeiro PG, Ghione P, Ni A, et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg 2020;73(05):841-846   DOI
26 Zucca E, Bertoni F, Vannata B, Cavalli F. Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas. Clin Cancer Res 2014;20(20):5207-5216   DOI
27 Hart AM, Lechowicz MJ, Peters KK, Holden J, Carlson GW. Breast implant-associated anaplastic large cell lymphoma: report of 2 cases and review of the literature. Aesthet Surg J 2014;34(06):884-894   DOI
28 Kadin ME, Morgan J, Xu H, et al. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis. Hum Pathol 2018;78:54-62   DOI
29 O'Shaughnessy K. Evolution and update on current devices for prosthetic breast reconstruction. Gland Surg 2015;4(02):97-110   DOI
30 Atlan M, Nuti G, Wang H, Decker S, Perry T. Breast implant surface texture impacts host tissue response. J Mech Behav Biomed Mater 2018;88:377-385   DOI
31 Manikkam Umakanthan J, McBride CL, Greiner T, et al. Bariatric implant-associated anaplastic large-cell lymphoma. J Oncol Pract 2017;13(12):838-839   DOI
32 Blombery P, Thompson ER, Jones K, et al. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica 2016;101(09):e387-e390   DOI
33 Laurent C, Nicolae A, Laurent C, et al. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. Blood 2020;135(05):360-370
34 Di Napoli A, Jain P, Duranti E, et al. Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. Br J Haematol 2018;180(05):741-744   DOI
35 Shauly O, Gould DJ, Siddiqi I, Patel KM, Carey J. The first reported case of gluteal implant-associated anaplastic large cell lymphoma (ALCL). Aesthet Surg J 2019;39(07):NP253-NP258   DOI
36 Engberg AK, Bunick CG, Subtil A, Ko CJ, Girardi M. Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sezary syndrome. J Clin Oncol 2013;31(06):e87-e89   DOI
37 Hallab NJ, Samelko L, Hammond D. The inflammatory effects of breast implant particulate shedding: comparison with orthopedic implants. Aesthet Surg J 2019;39(Suppl 1):S36-S48   DOI
38 Clemens MW, Miranda RN. Coming of age: breast implant-associated anaplastic large cell lymphoma after 18 years of investigation. Clin Plast Surg 2015;42(04):605-613   DOI
39 Story SK, Schowalter MK, Geskin LJ. Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders. Oncologist 2013;18(03):301-307   DOI
40 Kellogg BC, Hiro ME, Payne WG. Implant-associated anaplastic large cell lymphoma: beyond breast prostheses. Ann Plast Surg 2014;73(04):461-464   DOI
41 Palraj B, Paturi A, Stone RG, et al. Soft tissue anaplastic large T-cell lymphoma associated with a metallic orthopedic implant: case report and review of the current literature. J Foot Ankle Surg 2010;49(06):561-564   DOI
42 Chiarle R, Simmons WJ, Cai H, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med 2005;11(06):623-629   DOI
43 Leberfinger AN, Behar BJ, Williams NC, et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg 2017;152(12):1161-1168   DOI
44 NCCN. National Comprehensive Cancer Network. C2021. Available at: https://www.nccn.org/professionals/physician_gls/pdf/tcell.pdf
45 Miranda RN, Aladily TN, Prince HM, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol 2014;32(02):114-120   DOI
46 Lechner MG, Lade S, Liebertz DJ, et al. Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer 2011;117(07):1478-1489   DOI
47 Feldman AL, Dogan A, Smith DI, et al. Discovery of recurrent t(6;7) (p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood 2011;117(03):915-919   DOI
48 Vase MO, Friis S, Bautz A, Bendix K, Sorensen HT, d'Amore F. Breast implants and anaplastic large-cell lymphoma: a danish population-based cohort study. Cancer Epidemiol Biomarkers Prev 2013;22(11):2126-2129   DOI
49 Campanale A, Di Napoli A, Ventimiglia M, et al. Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients. Eur J Cancer 2021;148:277-286   DOI
50 Brody GS. The case against biofilm as the primary initiator of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 2016;137(04):766e-767e   DOI
51 Loch-Wilkinson A, Beath KJ, Knight RJW, et al. Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 2017;140(04):645-654   DOI
52 Yoon HJ, Choe JY, Jeon YK. Mucosal CD30-positive T-cell lymphoproliferative disorder arising in the oral cavity following dental implants: report of the first case. Int J Surg Pathol 2015;23(08):656-661   DOI
53 Clemens MW, Medeiros LJ, Butler CE, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol 2016;34(02):160-168
54 Kim IK, Hong KY, Lee CK, et al. Analysis of the molecular signature of breast implant-associated anaplastic large cell lymphoma in an Asian patient. Aesthet Surg J 2021;41(05):NP214-NP222   DOI
55 Dashevsky BZ, Gallagher KM, Grabenstetter A, et al. Breast implant-associated anaplastic large cell lymphoma: clinical and imaging findings at a large US cancer center. Breast J 2019;25(01):69-74   DOI
56 Mehta-Shah N, Clemens MW, Horwitz SM. How I treat breast implant-associated anaplastic large cell lymphoma. Blood 2018;132(18):1889-1898   DOI
57 Lazzeri D, Agostini T, Bocci G, et al. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer 2011;11(05):283-296   DOI
58 Yoon ES. Current status of breast implant-associated anaplastic large cell lymphoma in South Korea. J Korean Med Assoc 2021;64:5-9   DOI
59 Marra A, Viale G, Pileri SA, et al. Breast implant-associated anaplastic large cell lymphoma: a comprehensive review. Cancer Treat Rev 2020;84:101963   DOI
60 Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 2019;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S   DOI
61 de Boer M, van Leeuwen FE, Hauptmann M, et al. Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol 2018;4(03):335-341   DOI
62 Crescenzo R, Abate F, Lasorsa E, et al; European T-Cell Lymphoma Study Group, T-Cell Project: Prospective Collection of Data in Patients with Peripheral T-Cell Lymphoma and the AIRC 5xMille Consortium "Genetics-Driven Targeted Management of Lymphoid Malignancies" Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 2015;27(04):516-532   DOI
63 Parrilla Castellar ER, Jaffe ES, Said JW, et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 2014;124(09):1473-1480   DOI
64 Oishi N, Brody GS, Ketterling RP, et al. Genetic subtyping of breast implant-associated anaplastic large cell lymphoma. Blood 2018;132(05):544-547   DOI
65 Laurent C, Haioun C, Brousset P, Gaulard P. New insights into breast implant-associated anaplastic large cell lymphoma. Curr Opin Oncol 2018;30(05):292-300   DOI
66 Doren EL, Miranda RN, Selber JC, et al. U.S. Epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 2017;139(05):1042-1050   DOI
67 Jacombs A, Tahir S, Hu H, et al. In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg 2014;133(04):471e-480e   DOI
68 Clemens MW, McGuire PA. Discussion: a prospective approach to inform and treat 1340 patients at risk for BIA-ALCL. Plast Reconstr Surg 2019;144(01):57-59   DOI
69 Kadin ME, Deva A, Xu H, et al. Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J 2016;36(07):773-781   DOI
70 Decision du 02/04/2019 portant interdiction de mise sur le marche, de distribution, de publicite et d'utilisation d'implants mammaires a enveloppe macro-texturee et d'implants mammaires polyurethane, ainsi que retrait de ces produits. c2021. Available at: https://ansm.sante.fr/Decisions/Injonctions-decisions-de-police-sanitaire-sanctions-financieres-interdictionsde-publicite-Decisions-de-police-sanitaire/Decisiondu-02-04-2019-portant-interdiction-de-mise-sur-le-marche-de-distribution-de-publicite-et-d-utilisation-d-implants-mammaires-aenveloppe-macro-texturee-et-d-implants-mammaires-polyurethane-ainsi-que-retrait-de-ces-produits
71 Armitage JO. Staging non-Hodgkin lymphoma. CA Cancer J Clin 2005;55(06):368-376   DOI
72 Ghosh T, Duncavage E, Mehta-Shah N, McGuire PA, Tenenbaum M, Myckatyn TM. A cautionary tale and update on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 2020;40(12):1288-1300   DOI
73 Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997;100(02):554-555   DOI
74 Taylor CR, Siddiqi IN, Brody GS. Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol 2013;21(01):13-20   DOI
75 Duvic M, Moore D, Menter A, Vonderheid EC. Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol 1995;32(06):939-942   DOI
76 Adrada BE, Miranda RN, Rauch GM, et al. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat 2014;147(01):1-14   DOI
77 Clemens MW, Brody GS, Mahabir RC, Miranda RN. How to diagnose and treat breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 2018;141(04):586e-599e   DOI
78 Clemens MW, Horwitz SM. NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J 2017;37(03):285-289   DOI
79 Swerdlow SH, Campo E, Harris N, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2017
80 Vasmatzis G, Johnson SH, Knudson RA, et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 2012;120(11):2280-2289   DOI
81 Warschkow R, Cerny T, Schmied BM, Guller U, Thuerlimann B, Joerger M. A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. Br J Cancer 2016;115(01):80-84   DOI
82 Quesada AE, Zhang Y, Ptashkin R, et al. Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway. Breast J 2021;27(04):314-321   DOI
83 Turner SD, Inghirami G, Miranda RN, Kadin ME. Cell of origin and immunologic eventsin the pathogenesis of breast implant-associated anaplastic large-cell lymphoma. Am J Pathol 2020;190(01):2-10   DOI